Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression

(2021) Max Lenz et al.   Biomedicines

Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI. A Systematic Review and Meta-Analysis

(2020) Motasem Alyamani et al.   CANADIAN JOURNAL OF CARDIOLOGY

Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention

(2020) Keqing Hu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels

(2020) Mohammed O. Kseibati et al.   LIFE SCIENCES

Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients With STEMI and Multivessel Disease Who Underwent Successful PCI Using Drug-Eluting Stents

(2020) Yong Hoon Kim et al.   ANGIOLOGY

Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

(2018) Chunguang Feng et al.   Heart Lung and Circulation

Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction

(2018) H.C.F. Schram et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)

(2018) Wael Sumaya et al.   THROMBOSIS AND HAEMOSTASIS

Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry

(2018) Stavroula Papapostolou et al.   EuroIntervention

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

(2018) Qi Qi et al.   MEDICAL SCIENCE MONITOR

Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction

(2018) Rosalba C. García-Méndez et al.   ARCHIVES OF MEDICAL RESEARCH

Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2015) Turgay Celik et al.   ANGIOLOGY

Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial

(2015) CHUNHONG CHEN et al.   Experimental and Therapeutic Medicine

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

(2012) Patrick T. O’Gara et al.   CIRCULATION

Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction

(2010) Renpei Kobatake et al.   HEART AND VESSELS